You searched for: infliksimab (Estniska - Engelska)

infliksimab
infliximab

infliksimab + mtx
infliximab + mtx

flixabi infliksimab
flixabi infliximab

infliksimab (infliximabum)
infliximab

toimeaine on infliksimab.
the active substance is infliximab.

infliksimab 5 mg/kg
infliximab 5 mg/kg

infliksimab (16. nädal
infliximab (week 16)

infliksimab (nädal 16)
(week 16)

infliksimab randomiseeritud uuringus
infliximab subjects randomized

ravimi toimeaine on infliksimab.
it contains the active substance infliximab.

platseebo → infliksimab 10. nädal
week 10

infliksimab ja aza kombineeritud teraapiana
combination therapy

mida remicade sisaldab • toimeaine on infliksimab.
what remicade contains • the active substance is infliximab.

remicade 100 mg infusioonilahuse kontsentraadi pulber infliksimab
remicade 100 mg powder for concentrate for solution for infusion infliximab

muutmata kujul infliksimab ei ole uriinis määratav.
unchanged infliximab was not detected in urine.

infliksimab säilitusravi (5 mg/kg) (n = 96)
infliximab maintenance (5 mg/kg) (n=96)

platseebo → infliksimab 5 mg/kg (24ndal nädalal)
placebo → infliximab 5 mg/kg (at week 24)

on teadmata, kas infliksimab eritub rinnapiima ja imiku organismi.
it is unknown whether infliximab is excreted in human milk or absorbed systemically after ingestion.

infliksimab pärsib tnfα funktsionaalset aktiivsust mitmetes in vitro katsetes.
infliximab inhibits the functional activity of tnfα in a wide variety of in vitro bioassays.

infliksimab on teatud tüüpi valk, mis pärineb inimesest ja hiirest.
infliximab is a type of protein of human and mouse origin.